{
  "pmcid": "10247904",
  "sha256": "155147e1daab8429735ce5b959b521eda19710fc3f3f0c07c1d12cae06a823bd",
  "timestamp_utc": "2025-11-09T23:04:31.104585+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 9.527079875518677,
    "reading_ease": 44.64353820885202,
    "word_count": 241
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Tricuspid Annuloplasty During Mitral Valve Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In a multicenter, randomised controlled trial, 401 patients were randomised"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "401 patients were randomised to MVS alone (n=203) or MVS with TA (n=198)"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the composite rate of death, re-operation for TR, or TR progression at 2 years."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not specified."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "401 patients were randomised to MVS alone (n=203) or MVS with TA (n=198)"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "A PPM was implanted in 36 patients (9.6%; 95% CI 6.8%−13.0%) within 2 years, with 30/187 (16.0%) in the MVS+TA group and 6/188 (3.2%) in the MVS group (RR 5.08; 95% CI 2.16–11.94; p<0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "A PPM was implanted in 36 patients (9.6%; 95% CI 6.8%−13.0%) within 2 years"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  }
}